Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Tumor Gastrointestinal, Hormone-Secreting”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Very early researchActive Not RecruitingNCT03044977

What this trial is testing

Study to Evaluate the Safety of Combining Two Radionuclide Therapies to Treat Mid-gut Neuroendocrine Tumors

Who this might be right for

Neuroendocrine Tumor, MalignantNeuroendocrine Tumor Gastrointestinal, Hormone-Secreting

David Bushnell 20

Not applicableStudy completedNCT03834701

What this trial is testing

Endoscopic Ultrasound-guided RadioFrequency Ablation for the Treatment Pancreatic NeuroEndocrine Neoplasms

Who this might be right for

Neuroendocrine TumorsNeuroendocrine CarcinomaPancreas Neoplasm+1 more

Catholic University of the Sacred Heart 60

Testing effectiveness (Phase 2)WithdrawnNCT00003514

What this trial is testing

Antineoplaston Therapy in Treating Patients With Neuroendocrine Tumor That Is Metastatic or Unlikely to Respond to Surgery or Radiation Therapy

Who this might be right for

Merkel Cell CarcinomaIslet Cell CarcinomaNeuroendocrine Carcinoma+1 more

Burzynski Research Institute

Early research (Phase 1)Study completedNCT00006368

What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for

Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more

Novartis Pharmaceuticals 60